Diabetes drug may aid weight loss in people with HIV
Study finds diabetes is associated with a 25% reduction in concentration of tenofovir in blood spot samples, but what are the causes and consequences?
Diabetes raises the risk of liver damage in people with HIV
No increased risk of diabetes with integrase inhibitors in people starting HIV treatment
People with HIV at greater risk of COVID-19 death in South African study
Changes in fat cells on HIV treatment may have long-term metabolic consequences
Weight gain on antiretroviral treatment raises risk of diabetes
Older people living with HIV have an increased risk of chronic diseases associated with ageing
People with HIV aged 75 and older receiving good HIV care but many at risk of frailty
